T. Rowe Price Investment Management, Inc. Seagen Inc. Transaction History

T. Rowe Price Investment Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$191.51 - $216.16 $210,661 - $237,776	1,100 Added 0.18%	600,176 $127 Million
Q2 2023 Aug 14, 2023	SELL	$187.64 - $206.25 $192 Million - $211 Million	-1,023,147 Reduced 63.07%	599,076 $115 Million
Q1 2023 May 15, 2023	BUY	$127.59 - $203.08 $689,751 - $1.1 Million	5,406 Added 0.33%	1,622,223 $328 Million
Q4 2022 Feb 14, 2023	BUY	$117.37 - $139.17 $215,373 - $255,376	1,835 Added 0.11%	1,616,817 $208 Million
Q3 2022 Nov 14, 2022	BUY	$135.27 - $180.11 $218 Million - $291 Million	1,614,982 New	1,614,982 $221 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of T. Rowe Price Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on T. Rowe Price Investment Management, Inc. with notifications on news.